Siv Lise Bedringaas | University of Bergen

Siv Lise

Bedringaas

Chief Engineer

Visit Address:

Haukeland universitetssykehus, Laboratoriebygget

5021 Bergen

Postal Address:

Postboks 7804

5021 Bergen

Phone:

+47 55 97 30 59

E-mail:

Journal articles

Hatfield, Kimberley Joanne; Bedringaas, Siv Lise; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2010. OXYGEN LEVELS INFLUENCE THE CYTOKINE RELEASE PROFILE OF AML CELLS. Experimental Hematology. 38: S119-S119.
Hatfield, Kimberley Joanne; Bedringaas, Siv Lise; Ryningen, Anita; Gjertsen, Bjørn Tore; Bruserud, Øystein. 2010. Hypoxia increases HIF-1 alpha expression and constitutive cytokine release by primary human acute myeloid leukaemia cells. European Cytokine Network. 21: 154-164. doi: 10.1684/ecn.2010.0204

Wergeland, Line; Oveland, Eystein; Sjøholt, Gry; Bedringaas, Siv Lise; Hovland, Randi; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2008. FLT3 internal tandem duplication involving its libiquitin dependent endocytosis motif suspend modulation by HDM2 and are associated with inferior survival in AML. Haematologica. 93: 10-10.

Parlati, Francesco; Aujay, Monette; Bedringaas, Siv Lise; Demo, Susan; Gjertsen, Bjørn Tore; Goldstein, Eileen; Jiang, Jing; Kirk, Christopher; Laidig, Guy; Lorens, James; Lu, Yan; Micklem, David Robert; Ruurs, Paulina; Shenk, Kevin; Sylvain, Catherine; Sun, Congcong; Woo, Tina; Zhou, Han-Jie; Bennett, Mark. 2007. Anti-tumor activity of immunoproteasome selective inhibitors. Blood. 110: 477A-478A.
Wergeland, Line; Oveland, Eystein; Sjøholt, Gry; Bedringaas, Siv Lise; Hovland, Randi; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2007. Flt3 mutations in proximity to an ubiquitin dependent endocytosis motif suspend its Hdm2 modulation. Blood. 110: 148B-148B.

Sjøholt, Gry; Bedringaas, Siv Lise; Døskeland, Anne Paulus; Gjertsen, Bjørn Tore. 2006. Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML). Current Pharmaceutical Biotechnology. 7: 159-170. doi: 10.2174/138920106777549759
Sjøholt, Gry; Bedringaas, Siv Lise; Døskeland, Anne Paulus; Gjertsen, Bjørn Tore. 2006. Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML). Current Pharmaceutical Biotechnology. 7: 159-170. doi: 10.2174/138920106777549759

Reports and theses

Bedringaas, Siv Lise. 1992. Tranfeksjon av den humane thyrocyt cellelinjen SGHTL-34 med oncogener og optimalisering av tranfeksjonsbetingelser. [Mangler utgivernavn].